Cargando…
Identification of Serum microRNA-25 as a novel biomarker for pancreatic cancer
To identify serum microRNA-25 (miR-25) as a diagnostic biomarker for pancreatic cancer (PCa) and to evaluate its supplementary role with serum carbohydrate antigen 19-9 (CA19-9) in early identification of cancers. Eighty patients with pancreatic cancer and 91 non-cancer controls were enrolled in thi...
Autores principales: | Yu, Yiwen, Tong, Ying, Zhong, Ailing, Wang, Yanchun, Lu, Renquan, Guo, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769376/ https://www.ncbi.nlm.nih.gov/pubmed/33350781 http://dx.doi.org/10.1097/MD.0000000000023863 |
Ejemplares similares
-
Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma
por: Zhang, Ying, et al.
Publicado: (2017) -
Identification of potential serum exosomal microRNAs involved in acinar-ductal metaplasia that is a precursor of pancreatic cancer associated with chronic pancreatitis
por: Sheng, Li-Ping, et al.
Publicado: (2021) -
Overexpression of microRNA let-7 correlates with disease progression and poor prognosis in hepatocellular carcinoma
por: Shi, Wenxia, et al.
Publicado: (2017) -
Appraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection: A Meta-Analysis
por: Hou, Yi, et al.
Publicado: (2016) -
The value of microRNA-21 as a biomarker for the prognosis of lung cancer: A protocol for systematic review and meta-analysis
por: Zhang, Wei, et al.
Publicado: (2020)